US Pharmaceutical Isolator Market

ID: MRFR/Pharma/18464-HCR
100 Pages
Satyendra Maurya
Last Updated: April 24, 2026
US Pharmaceutical Isolator Market Research Report: Size, Share, Trend Analysis By Product Type (Open Isolator, Closed Isolator), By Product Type (Sterility Test Isolator, Process Isolator, Decontamination Pass Box), By Product Class (ISO Class 3, ISO Class 5), By Applications (Sterility Testing, Sampling/ Weighing/ Distribution, Animal Laboratories, Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling, Defiltration and Drying, Others) and By End Users (BioPharma/Cell & Gene therapy Companies, Academic & Research Institutes, Hospitals, Contract Research Organization & Contract Manufacturing Organization) - Growth Outlook & Industry Forecast 2025 To 2035
US Pharmaceutical Isolator Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)9.85%
2024 Market Size$ 2,100 Million
2025 Market Size$ 2,306.85 Million
2035 Market Size$ 5,900 Million
Key Players
Sartorius
Getinge
Thermo Fisher Scientific
Merck KGaA
Eppendorf
Aseptic Technologies
Trends
  • Technological Advancements
  • Regulatory Compliance
  • Focus on Aseptic Processing
Opportunities
  • Increased Focus on Quality Control
  • Rising Demand for Biopharmaceuticals
  • Technological Innovations in Isolator Design
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Chemicals and Materials, BY Type (USD Million)
      1. 4.1.1 Open Isolator
      2. 4.1.2 Closed Isolator
    2. 4.2 Chemicals and Materials, BY Product Type (USD Million)
      1. 4.2.1 Sterility Test Isolator
      2. 4.2.2 Process Isolator
      3. 4.2.3 Decontamination Pass Box
    3. 4.3 Chemicals and Materials, BY Product Class (USD Million)
      1. 4.3.1 ISO Class 3
      2. 4.3.2 ISO Class 5
    4. 4.4 Chemicals and Materials, BY Application (USD Million)
      1. 4.4.1 Sterility Testing
      2. 4.4.2 Sampling/ Weighing/ Distribution
      3. 4.4.3 Animal Laboratories
      4. 4.4.4 Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling
      5. 4.4.5 Defiltration and Drying
      6. 4.4.6 Others
    5. 4.5 Chemicals and Materials, BY End User (USD Million)
      1. 4.5.1 BioPharma/Cell & Gene therapy Companies
      2. 4.5.2 Academic & Research Institutes
      3. 4.5.3 Hospitals
      4. 4.5.4 Contract Research Organization & Contract Manufacturing Organization
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Sartorius (DE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Getinge (SE)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Thermo Fisher Scientific (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Merck KGaA (DE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Eppendorf (DE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Aseptic Technologies (BE)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Fedegari (IT)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Cytiva (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Baker (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY TYPE
    3. 6.3 US MARKET ANALYSIS BY PRODUCT TYPE
    4. 6.4 US MARKET ANALYSIS BY PRODUCT CLASS
    5. 6.5 US MARKET ANALYSIS BY APPLICATION
    6. 6.6 US MARKET ANALYSIS BY END USER
    7. 6.7 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF CHEMICALS AND MATERIALS
    10. 6.10 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    12. 6.12 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
    13. 6.13 CHEMICALS AND MATERIALS, BY TYPE, 2024 (% SHARE)
    14. 6.14 CHEMICALS AND MATERIALS, BY TYPE, 2024 TO 2035 (USD Million)
    15. 6.15 CHEMICALS AND MATERIALS, BY PRODUCT TYPE, 2024 (% SHARE)
    16. 6.16 CHEMICALS AND MATERIALS, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    17. 6.17 CHEMICALS AND MATERIALS, BY PRODUCT CLASS, 2024 (% SHARE)
    18. 6.18 CHEMICALS AND MATERIALS, BY PRODUCT CLASS, 2024 TO 2035 (USD Million)
    19. 6.19 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
    20. 6.20 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
    21. 6.21 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
    22. 6.22 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY PRODUCT CLASS, 2025-2035 (USD Million)
      4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
      5. 7.2.5 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Pharmaceutical Isolator Market Segmentation

US Pharmaceutical Isolator Market By Type (USD Million, 2025-2035)

  • Open Isolator
  • Closed Isolator

US Pharmaceutical Isolator Market By Product Type (USD Million, 2025-2035)

  • Sterility Test Isolator
  • Process Isolator
  • Decontamination Pass Box

US Pharmaceutical Isolator Market By Product Class (USD Million, 2025-2035)

  • ISO Class 3
  • ISO Class 5

US Pharmaceutical Isolator Market By Application (USD Million, 2025-2035)

  • Sterility Testing
  • Sampling/ Weighing/ Distribution
  • Animal Laboratories
  • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling
  • Defiltration and Drying
  • Others

US Pharmaceutical Isolator Market By End User (USD Million, 2025-2035)

  • BioPharma/Cell & Gene therapy Companies
  • Academic & Research Institutes
  • Hospitals
  • Contract Research Organization & Contract Manufacturing Organization

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.